Table 2.
Phytocannabinoids | Therapeutic Effects | Citations |
---|---|---|
THC |
Modulation of pain, spasticity, sedation, and mood; Bronchodilator; Neuroprotective and antioxidant; Antipruritic in cholestatic jaundice; Anti-inflammatory (power: 20× aspirin and 2× hydrocortisone); Analgesic; Anti-nausea/emesis (which is induced by chemotherapy); Appetite promoter Antitumorogenic |
[10,11,12,13,14,15,16,17,18] |
CBD |
Anticonvulsive; Anti-inflammatory and immunosuppressive (psoriasis, atopic dermatitis, and abrasions); Neuroprotective and antioxidative; Antipsychotic; Counteracts the intoxicating effects of cannabis; Anxiolytic; Addiction treatment; Antimicrobial (Gram-positives bacterial cutaneous infections); Antitumour |
[11,12,14,17,18,19,20,21] |
CBG |
Muscle relaxant; Analgesic; Antifungal (modest); Antineoplastic; Antidepressant; Inhibition of keratinocyte proliferation in psoriasis; Antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA); |
[11,12,14,17,18,21] |
CBC |
Analgesic; Anti-inflammatory |
[8,9,13] |
CBN |
Sedative; Anticonvulsive; Anti-inflammatory; Antibiotic (with anti-MRSA activity); Inhibition of keratinocyte proliferation; Osteogensis promoting |
[11,12,14] |
THCV |
Promotion of weight loss; Anticonvulsive; Suppression of hyperalgesia and inflammation; Appetite suppression; Counteracts the intoxicating effects of THC |
[11,12,14] |
THCA-A |
Immunomodulatory; Anti-inflammatory; Neuroprotective; Antineoplastic |
[11,12,14] |
CBDV |
Anticonvulsant | [11,12,14] |